Medicine for preventing or treating rhinovirus infection
The present invention provides a pharmaceutical composition for preventing or treating human rhinovirus (HRV) infection. The composition comprises a hexaldehyde sugar wherein the hydroxyl group at carbon 2 of the hexaldehyde sugar is substituted with any one of H, F, Cl, Br, I, SH, Me, OMe and SMe,...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
21.07.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides a pharmaceutical composition for preventing or treating human rhinovirus (HRV) infection. The composition comprises a hexaldehyde sugar wherein the hydroxyl group at carbon 2 of the hexaldehyde sugar is substituted with any one of H, F, Cl, Br, I, SH, Me, OMe and SMe, such as 2-deoxyglucose. Furthermore, a dispenser for intranasal administration, such as a nasal nebulizer or nasal drip containing the pharmaceutical composition, is provided. In addition, an inhalation device, such as a metered dose inhaler, a dry powder inhaler or an atomizer, comprising the composition is provided.
本发明提供了用于预防或治疗人鼻病毒(HRV)感染的药物组合物。该组合物包含己醛糖,其中己醛糖的碳2处的羟基被H、F、Cl、Br、I、SH、Me、OMe和SMe中的任何一个取代,例如2-脱氧葡萄糖。此外,提供了用于鼻内给药的分配器,例如含有所述药物组合物的鼻喷雾器或滴鼻器。另外,提供了包含所述组合物的吸入装置,例如计量吸入器,干粉吸入器或雾化器。 |
---|---|
Bibliography: | Application Number: CN202310646037 |